Healthcare - Latest News, Analysis, Opinion

The company had posted a net profit of Rs 117.7 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.

Glenmark Pharma gets USFDA nod for Tacrolimus capsules

Tacrolimus capsule is an immunosuppressant and is used for preventing organ rejection in certain patients following liver, kidney, or heart transplant.

Third wave of COVID-19 in Delhi worst so far; cases to come down soon: Health Minister Jain

The government has increased the number of beds for COVID-19 patients in hospitals in Delhi, but there is no plan to rope in hotels and banquet halls

Novartis Arthritis Drug Fails To Help COVID-19 Patients

The medicine, approved as Ilaris for juvenile arthritis and other conditions, also did not meet its key secondary endpoint of reducing COVID-19 mortality in a late-phase clinical trial

AstraZeneca Expects COVID-19 Vaccine Data This Year

While AstraZeneca marches on with the vaccine, demand for its diverse portfolio of drugs remained strong despite disruptions to health systems due to the pandemic.

Lupin Q2 Net Profit At Rs 211 Cr

Consolidated total revenue from operations of the company stood at Rs 3,835 crore for the quarter under consideration. It was Rs 3,822.21 crore for the same period a year ago

Sun Pharma Q2 Net Profit Up 70% At Rs 1,813 Cr

The company had posted a net profit of Rs 1,064.09 crore for the corresponding period of the previous fisca

Pfizer Q2 Net Profit Declines 15% At To 131.37 Cr

The company had posted a net profit of Rs 154.25 crore for the corresponding period of the previous fiscal

“Increase Number Of Covid-19 Tests”

Poulami Chakraborty

Despite Mumbai being one of the most Covid-19 affected areas, efforts from NGOs and political parties have hugely helped in bringing the situation under control

Delhi sees another record virus cases with over 5,700; AAP govt cites new strategy leading to rise

The Union Health Ministry, however, said social gatherings during festivities, deteriorating air quality, increasing incidences of respiratory disorders are among a few reasons attributed to the rise in COVID-19 cases in Delhi.

Bharat Biotech in talks to take vaccine candidate global

The company, based in Hyderabad, this week received initial approval from Indian authorities to conduct late-stage trials for its vaccine candidate, COVAXIN.

AstraZeneca says its Oxford vaccine deal allows it to add up to 20% of manufacturing costs

AstraZeneca has previously signed multiple supply-and-manufacture deals for more than 3 billion doses globally.

Need To Continue Extreme Caution Against COVID-19: WHO

The upcoming festival season and the approaching winter/cold season threatens to aggravate the situation if we let our guards down

AstraZeneca Wins Two Approval Recommendations From EU Agency